New bioprinting technology to be developed by UMC Utrecht, regenHU (VIDEO)

New bioprinting technology to be developed by UMC Utrecht, regenHU. Partnering experts in 3D bioprinting with experts in biomanufacturing has resulted in the first melt electrospinning device that incorporates the use of bio-inks. Housed at the Utrecht Biofabrication Facility, this combination of techniques may lead to improved and more accurate 3D bioprinting for therapeutic use. The Utrecht Biofabrication Facility was established with support of Utrecht University and the UMC Utrecht in 2013.

Partnering experts in 3D bioprinting with experts in biomanufacturing has resulted in the first melt electrospinning device that incorporates the use of bio-inks. Housed at the Utrecht Biofabrication Facility, this combination of techniques may lead to improved and more accurate 3D bioprinting for therapeutic use. The Utrecht Biofabrication Facility was established with support of Utrecht University and the UMC Utrecht in 2013.

The melt electrospinning device will be tested with bio-inks to optimize the integration of these two systems in order to generate composite materials and determine the performance of the cells used in the bio-inks.

“As a biomanufacturing company, we are excited to work with researchers at the Regenerative Medicine Center Utrecht who are at the forefront of bio-ink development and 3D printing,” says Marc Thurner, CEO of regenHU. “It’s important to synergize our strengths in order to bring new technologies to fruition.”

The accuracy, increased fibre strength and breadth of this new bioprinting technology will enable researchers to make structures that more closely resemble the complex architecture and function of real tissues. Such constructs can be used to study disease, drug efficacy and toxicity, and to create regenerative implants.

RegenHU is an innovative biomedical company located in Switzerland. regenHU acts as a bio-system architect developing new bio-manufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. regenHU’s proven and cutting-edge solutions are being implemented globally. regenHU benefits from exclusive patented technologies resulting from many years of research within international universities and partners.

 

source:press.uu.nl

read more…